France· FR:64833033
MYCOPHENOLATE MOFETIL BIOGARAN 250 mg, gélule
A medicinal product containing mycophénolate mofétil, registered in France by BIOGARAN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MYCOPHÉNOLATE MOFÉTIL
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400949179596plaquette(s) PVC PVDC aluminium de 100 gélule(s)EUR 50.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mycophénolate mofétil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArzip 250mg capsulesZentiva Pharma UK Ltd
- United StatesCellCeptGenentech, Inc.
- CzechiaCELLCEPTRoche Registration GmbH, Grenzach-Wyhlen
- FinlandCellceptAbacus Medicine A/S
- SwedenCellCept 250 mg Kapsel, hårdRoche Registration GmbH
- IrelandCellCept 250 mg Capsule, hardRoche Registration GmbH
- CanadaACH-MYCOPHENOLATEACCORD HEALTHCARE INC
- BelgiumCellcept 250 mgRoche Registration
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mowel, Mycophenolat Mofetil Sandoz
- Belgium · Mycophenolat Mofetil Sandoz
- Bulgaria · Микофенолат Мофетил Акорд
- Czechia · Mycophenolat Mofetil Sandoz
- Germany · Mowel, Mycophenolat 1 A Pharma
- Denmark · Mycophenolate Mofetil Hexal, Mycophenolatmofetil Accord
- Estonia · Mycophenolate Mofetil Accord
- Spain · Micofenolato De Mofetilo Accord, Micofenolato De Mofetilo Aristo
- Finland · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- United Kingdom (Northern Ireland) · Mycophenolate Hexal, Mycophenolate Mofetil
- Croatia · Mofetilmikofenolat Tillomed, Trixin
- Ireland · Mycolat, Mycophenolate Mofetil Accord
- Iceland · Cellcept, Myclausen
- Italy · Micofenolato Mofetile Accord, Micofenolato Mofetile Ahcl
- Liechtenstein · Cellcept, Myclausen
- Lithuania · Mycophenolate Mofetil Accord
- Latvia · Mycophenolate Mofetil Accord
- Malta · Mycophenolate Mofetil Ascend
- Netherlands · Mycofenolaat Mofetil Accord, Mycofenolaat Mofetil Sandoz
- Norway · Cellcept, Myclausen
- Poland · Mycofit, Mycophenolate Mofetil Sandoz
- Portugal · Micofenolato De Mofetil Accord, Micofenolato De Mofetil Aristo
- Romania · Micofenolat Mofetil Sandoz
- Sweden · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- Slovakia · Mykofenolát Mofetil Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9b3dd68-48ef-479d-982f-8b294b2e3a16 GET /v1/drugs/e9b3dd68-48ef-479d-982f-8b294b2e3a16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64833033",
"date_amm": "2010-06-28",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MYCOPHÉNOLATE MOFÉTIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mycophénolate mofétil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.